Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Rational design, synthesis and biological evaluation of novel 2-(substituted amino)-[1,2,4]triazolo[1,5-a]pyrimidines as novel tubulin polymerization inhibitors
Lin Chen, Tangyang Ji, Xian‐Sen Huo, et al.
European Journal of Medicinal Chemistry (2022) Vol. 244, pp. 114864-114864
Closed Access | Times Cited: 21

Showing 21 citing articles:

Design, synthesis and biological evaluation of 1,2,3-triazole benzothiazole derivatives as tubulin polymerization inhibitors with potent anti-esophageal cancer activities
Bowen Wu, Wenjing Huang, Yunhe Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 265, pp. 116118-116118
Closed Access | Times Cited: 7
The discovery of novel N-heterocyclic-based AKT inhibitors with potential efficacy against prostate cancer
Jinxiao Sun, Dezhi Yang, Yongmi Huang, et al.
European Journal of Medicinal Chemistry (2025) Vol. 289, pp. 117435-117435
Closed Access
Design, synthesis and biological evaluation of CDC20 inhibitors for treatment of triple-negative breast cancer
Shifang Zhao, Jiafu Leng, Shanshan Xie, et al.
European Journal of Medicinal Chemistry (2024) Vol. 268, pp. 116204-116204
Closed Access | Times Cited: 6
Targeting tubulin protein to combat fungal disease: Design, synthesis, and its new mechanistic insights of benzimidazole hydrazone derivatives
Mei Li, Yu Long, Lihui Shao, et al.
International Journal of Biological Macromolecules (2025), pp. 140226-140226
Closed Access
Discovery of 6-aryl-2-(3,4,5-trimethoxyphenyl)thiazole[3,2-b][1,2,4]triazoles as potent tubulin polymerization inhibitors
Na Li, Qi Guan, Yilang Hong, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115402-115402
Closed Access | Times Cited: 11
Discovery of novel 6-p-tolyl-3-(3,4,5-trimethoxybenzyl)-7H-[1,2,4]triazolo[3,4-b][1,3,4]thiadiazine derivative as a potent tubulin inhibitor with promising in vivo antitumor activity
Tangyang Ji, Xie‐Er Jian, Lin Chen, et al.
European Journal of Medicinal Chemistry (2023) Vol. 256, pp. 115437-115437
Closed Access | Times Cited: 11
Development of tubulin polymerization inhibitors as anticancer agents
Mudasir Nabi Peerzada, Mohammad Sultan Dar, Saurabh Verma
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 797-820
Closed Access | Times Cited: 11
Design, synthesis and biological evaluation of 4-arylamino-pyrimidine derivatives as focal adhesion kinase inhibitors
Zhiwu Long, Yaqing Zuo, Rongrong Li, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106792-106792
Closed Access | Times Cited: 9
Design of balanced dual-target inhibitors of EGFR and microtubule
Yifan Liu, Qiu-Ya Ma, Xiangyu Kong, et al.
Bioorganic Chemistry (2024) Vol. 143, pp. 107087-107087
Closed Access | Times Cited: 2
Recognition of arylmethylidene derivatives of imidazothiazolotriazinones as novel tubulin polymerization inhibitors
Alexei N. Izmest’ev, E. V. Svirshchevskaya, Sergey B. Akopov, et al.
RSC Medicinal Chemistry (2024) Vol. 15, Iss. 4, pp. 1258-1273
Closed Access | Times Cited: 2
Discovery of potent tubulin inhibitors targeting the colchicine binding site via structure-based lead optimization and antitumor evaluation
Wei Liu, Youyou He, Zhongjie Guo, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 6
Design, synthesis and biological evaluation of novel dihydroquinolin-4(1H)-one derivatives as novel tubulin polymerization inhibitors
Yuchen Tan, Han Hu, Wenjian Zhu, et al.
European Journal of Medicinal Chemistry (2023) Vol. 262, pp. 115881-115881
Closed Access | Times Cited: 6
An overview of the most used synthetic pathways of 1,2,4-triazolo[1,5-a]pyrimidines
Mohamed Nabil Zedan, Mai E. Shoman, Mohamed Abdel‐Aziz, et al.
Results in Chemistry (2024) Vol. 12, pp. 101903-101903
Open Access | Times Cited: 1
Novel hybrids of sclareol and 1,2,4-triazolo[1,5-a]pyrimidine show collateral sensitivity in multidrug-resistant glioblastoma cells
Pavle Stojković, Ana Kostić, Ema Lupšić, et al.
Bioorganic Chemistry (2023) Vol. 138, pp. 106605-106605
Closed Access | Times Cited: 4
Novel indolyl 1,2,4-triazole derivatives as potential anti-proliferative agents: in silico studies, synthesis, and biological evaluation
Sarah A. Ghobish, Khaled O. Mohamed, Nahla A. Farag, et al.
RSC Medicinal Chemistry (2023) Vol. 15, Iss. 1, pp. 293-308
Closed Access | Times Cited: 4
Tandem Ring‐Opening/Double Ring‐Closing Synthesis of 1,2,4‐Triazolo[1,5‐a]pyridines from Chromone‐Containing Acrylonitriles
Nikita M. Chernov, Roman P. Kustin, Yulia V. Pypa, et al.
Advanced Synthesis & Catalysis (2023) Vol. 366, Iss. 2, pp. 277-284
Closed Access | Times Cited: 2
Review; Recent approaches on Tubulin Polymerization inhibitors (2018-2022)
Azhar O. El-Abd
Delta University Scientific Journal (2024) Vol. 7, Iss. 1
Open Access
Ibuprofen-furo[2,3-d]pyrimidine-based Hybrid Bearing Triazole, Hydrazide and Oxadiazole as Potent Antitumor Agents: Design and Synthesis and Activity Evaluation
Chujie Liao, Chun Feng, Li Li, et al.
Journal of Molecular Structure (2024) Vol. 1319, pp. 139481-139481
Closed Access
Combretastatin A-4 based compounds as potential anticancer agents: A review
Moien A. Omar, Soha H. Emam, Demiana S. Mikhail, et al.
Bioorganic Chemistry (2024) Vol. 153, pp. 107930-107930
Closed Access
Synthesis and Antiproliferative Evaluation of New 1,3,5‐Trisubstituted 1,2,4‐Triazole Derivatives against Glioblastoma Cell Lines
Elif Beyza Koc, Bilgesu Onur Sucu
ChemistrySelect (2023) Vol. 8, Iss. 18
Closed Access
Discovery of novel tubulin CBSI (R)-9k from the indanone scaffold for the treatment of colorectal cancer
Zhipeng Huo, Delin Min, Shijie Zhang, et al.
RSC Medicinal Chemistry (2023) Vol. 14, Iss. 12, pp. 2738-2750
Open Access
Page 1

Scroll to top